Imported-post
-
Study underscores importance of personalized medicine in kidney cancer
A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions. Read MoreNovember 10, 2020
-
Hydroxychloroquine does not help patients hospitalized with COVID-19: Study
Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes. Read MoreNovember 9, 2020
-
VUMC begins study of second COVID-19 vaccine
Vanderbilt University Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. Read MoreNovember 2, 2020
-
Team examines operating limits in solid-state batteries to improve driving range of electric vehicles
There is huge momentum toward adoption of battery electric vehicles primarily because performances are meeting or exceeding the properties of traditional automobiles. Consumers want electric vehicles that have similar driving range (energy density) and charging styles and times (power density) to gasoline powered vehicles. “One pathway to improving the energy density of the battery, or... Read MoreOctober 22, 2020
-
Possible COVID-19 “decoy”
It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection. Read MoreOctober 15, 2020
-
AI-based tech to improve stroke outcomes
Two prototype devices could refine thrombectomy through sensory augmentation. Read MoreOctober 14, 2020
-
COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials
AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca. Read MoreOctober 13, 2020
-
Nominations sought for 2021 Vanderbilt Prize in Biomedical Science
Nominations for the 2021 Vanderbilt Prize in Biomedical Science are now being accepted. The nomination deadline is Dec. 11. Read MoreOctober 5, 2020
-
Team’s sustained work in T-cell immune response awarded P01 grant totaling $11 million
For more than a decade Matt Lang and collaborators across the U.S. have worked to recreate key components of T-cells and how they know when to start fighting disease. Conventional wisdom suggested that T-cells formed regular, force-free bonds with infected cells, and in doing so caused the chain reaction of immune response. The team slowly... Read MoreOctober 4, 2020
-
$8.7 million DARPA grant advances AI-assisted CPS design work
A new, $8.7 million project—Design. R–AI-assisted CPS Design—involves pathbreaking work for the Defense Advanced Research Projects Agency as future cyber-physical systems will rely less on human control and more machine learning algorithms and artificial intelligence processors. Read MoreOctober 4, 2020